Adding Merck ' s Keytruda To Chemo Halves Death Risk For Lung Cancer Patients

Another study combined Opdivo and Yervoy, two drugs made by Bristol-Myers Squibb, in lung cancer patients selected with a new type of diagnostic test. An third result hints that giving Opdivo earlier – before surgery to remove tumors – may lead to even more benefits for patients.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: NYSE:MRK NYSE:BMY Source Type: news